PB

Serial Number 97980002
Registration 7874633
700

Registration Progress

Application Filed
Mar 24, 2023
Under Examination
Apr 23, 2024
Approved for Publication
Feb 7, 2024
Published for Opposition
Feb 27, 2024
Registered
Jul 29, 2025

Trademark Image

PB

Basic Information

Serial Number
97980002
Registration Number
7874633
Filing Date
March 24, 2023
Registration Date
July 29, 2025
Published for Opposition
February 27, 2024
Drawing Code
5

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 29, 2025
Registration
Registered
Classes
042

Rights Holder

Parallel Biosystems, Inc.

03
Address
750 Main Street
Cambridge, MA 02139

Ownership History

Parallel Biosystems, Inc.

Original Applicant
03
Cambridge, MA

Parallel Biosystems, Inc.

Owner at Publication
03
Cambridge, MA

Parallel Biosystems, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Karen Won

USPTO Deadlines

Next Deadline
2010 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250729)
Due Date
July 29, 2031
Grace Period Ends
January 29, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

41 events
Date Code Type Description Documents
Jul 29, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jul 29, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 16, 2025 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jul 7, 2025 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jun 17, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 17, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 17, 2025 ALIE A ASSIGNED TO LIE Loading...
Jun 11, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 3, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 3, 2025 GNRT O NON-FINAL ACTION E-MAILED Loading...
Jun 3, 2025 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Apr 21, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Oct 23, 2024 IUAF S USE AMENDMENT FILED Loading...
Apr 21, 2025 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Oct 23, 2024 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Apr 21, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 23, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 21, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 21, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 17, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 23, 2024 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Oct 23, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Oct 23, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 23, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 23, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 23, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 23, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 4, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 27, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 7, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 7, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 24, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 8, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 7, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 7, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 22, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 22, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 22, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 19, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 16, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 28, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Medical scientific research testing, research and development services in the fields of immune organoids, immune system modeling, antibodies, pharmaceuticals, biologics, immunotherapies, and cell therapies; Drug discovery services; Biotechnology research and development services, namely, providing screening and analysis of immune responses, antibodies, human cells, and pharmaceutical and biologic therapies
First Use Anywhere: 20210500
First Use in Commerce: 20210500

Additional Information

Design Mark
The mark consists of the letters "P" and "B" in lower case displayed as a loop.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
PARALLEL BIO

Classification

International Classes
042